RESUMEN
Evocalcet is a novel calcimimetic agent for the treatment of secondary hyperparathyroidism (SHPT). This study evaluated the effects of evocalcet on inhibition and induction of cytochrome P450 (CYP) isozymes. Although drug interactions arising from reversible inhibition of CYP isozymes by evocalcet were considered unlikely based on the results of in vitro studies and static model analyses, the potential for evocalcet to cause time-dependent inhibition of CYP3A or induction of several CYP isozymes could not be ruled out. Therefore, a clinical drug-drug interaction (DDI) study to evaluate the effects of evocalcet on the pharmacokinetics (PKs) of probe substrates for CYP isozymes (CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP3A) was conducted in healthy male volunteers using a novel cocktail combination. Evocalcet did not significantly affect the PKs of the probe substrates, confirming that CYP-mediated interactions were unlikely.
Asunto(s)
Calcimiméticos/farmacocinética , Inhibidores Enzimáticos del Citocromo P-450/farmacocinética , Sistema Enzimático del Citocromo P-450/metabolismo , Naftalenos/farmacocinética , Pirrolidinas/farmacocinética , Administración Oral , Adulto , Alquinos , Benzoxazinas/administración & dosificación , Benzoxazinas/farmacocinética , Calcimiméticos/administración & dosificación , Carbamatos/administración & dosificación , Carbamatos/farmacocinética , Células Cultivadas , Ciclopropanos , Inhibidores Enzimáticos del Citocromo P-450/administración & dosificación , Interacciones Farmacológicas , Voluntarios Sanos , Hepatocitos , Humanos , Hiperparatiroidismo Secundario/tratamiento farmacológico , Concentración 50 Inhibidora , Isoenzimas/metabolismo , Masculino , Naftalenos/administración & dosificación , Oxidación-Reducción/efectos de los fármacos , Piperidinas/administración & dosificación , Piperidinas/farmacocinética , Cultivo Primario de Células , Pirrolidinas/administración & dosificación , Teofilina/administración & dosificación , Teofilina/farmacocinética , Adulto JovenRESUMEN
Diabetic retinopathy is one of the most frequent complications of diabetes and is a leading cause of vision loss in adulthood. To better understand the molecular pathophysiology of diabetic retinopathy, we performed comprehensive gene expression analysis of the mouse retina under diabetic conditions with an in-house cDNA microarray system that was designed to be suitable for the small amount of RNA available from a single mouse retina. Diabetes was induced in male C57BL/6 mice by an intraperitoneal injection of streptozotocin, and the changes in retinal mRNA levels were examined in three pairs of diabetic and age-matched control mice at 1 and 3 months after the injection of streptozotocin. Northern blot analysis with amplified total cRNA confirmed the increase in mRNA levels of several selected genes. Most of the significantly up-regulated genes could be classified into two functional categories: oxidative phosphorylation and protein turnover. All mitochondrial DNA-encoded and most of the nuclear DNA-encoded genes for oxidative phosphorylation were up-regulated in the diabetic retina. This was in sharp contrast with a previous report of a down-regulation of these genes in skeletal muscles of streptozotocin-induced diabetic mice and type 2 diabetic humans. Genes for protein synthesis and ubiquitin were also up-regulated in the diabetic retina, suggesting the increase in turnover rates for at least a part of the protein population. Taken together, the diabetic retina appears to be in a state activated for intermediary metabolism, presumably because of an increase in insulin-independent glucose influx. These results provide insights into possible preventive and therapeutic intervention of diabetic retinopathy.
Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Retinopatía Diabética/metabolismo , Proteínas del Ojo/biosíntesis , Retina/metabolismo , Regulación hacia Arriba , Animales , Proteínas del Ojo/genética , Biblioteca de Genes , Masculino , Ratones , Ratones Endogámicos C57BL , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Fosforilación Oxidativa , ARN Mensajero/genética , Ubiquitina/biosíntesis , Ubiquitina/genéticaRESUMEN
Fyn-tyrosine-kinase-deficient mice exhibit increased fearfulness and display enhanced excitability in the amygdala. To gain insight into the molecular changes associated with the increased excitability of the amygdala, we used a newly developed cDNA array system comprising mouse KIAA cDNA clones to identify novel genes differentially expressed in the amygdala of fyn(-/-) and fyn(+/-) mice following administration of N-methyl-D-aspartate (NMDA). Laser capture microdissection in combination with PCR-based cDNA amplification allowed us to analyze gene expression in each amygdalar subdivision. The statistical significance of the differential expressions was tested by one-way analysis of variance (ANOVA) by the false discovery rate controlling approach. Among the 805 mKIAA cDNA clones tested, only the expression level of mKIAA1577 (Zinc finger SWIM domain containing protein 6; gene name, Zswim6) showed statistically significant change in regard to the genotype and amygdalar subdivision. Namely, only the lowered expression of mKIAA1577 in the central nucleus of fyn(-/-) mice 1 h after NMDA administration (2.1-fold lower relative to fyn(+/-) mice) was statistically significant. In situ hybridization analysis confirmed the downregulation of the mRNA in the central nucleus of the fyn(-/-) mice 1 h after NMDA administration (3.2-fold lower relative to fyn(+/-) mice). The NMDA-induced change in gene expression was partially blocked by the NMDA antagonist D-AP-5. These results suggest that Fyn deficiency was responsible for the NMDA-induced downregulation of a specific gene in the amygdalar central nucleus.
Asunto(s)
Amígdala del Cerebelo/metabolismo , Regulación de la Expresión Génica/genética , Proteínas del Tejido Nervioso/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Proto-Oncogénicas c-fyn/deficiencia , 2-Amino-5-fosfonovalerato/farmacología , Amígdala del Cerebelo/anatomía & histología , Amígdala del Cerebelo/efectos de los fármacos , Análisis de Varianza , Animales , Interacciones Farmacológicas , Agonistas de Aminoácidos Excitadores/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Regulación de la Expresión Génica/efectos de los fármacos , Hibridación in Situ/métodos , Rayos Láser , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microdisección/métodos , N-Metilaspartato/farmacología , Proteínas del Tejido Nervioso/genética , Proteínas Nucleares/genética , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , ARN Mensajero/metabolismoRESUMEN
We developed an integrated system suitable for comprehensive gene expression studies including construction and analysis of cDNA microarrays starting from a small amount of mRNA. We amplified total mRNA first as cDNA mixtures by polymerase chain reaction and then as strand-specific cRNA mixtures by in vitro transcription. These amplified cDNA and cRNA enabled determination of mRNA levels by hybridization analyses such as Southern, Northern, reverse-Northern macroarray, and cDNA microarray analyses, as well as construction of the cDNA library with a unidirectional cDNA insert. By using strand-specific cRNA derived from rat primary-cultured hepatocytes, we detected putative antisense transcripts for the metallothionein gene. cDNA microarray analysis for genes regulated by glucocorticoids and glucagon in the hepatocytes revealed that a number of genes involved in signal transduction and transcriptional regulation were up- or down-regulated. The present system is widely applicable to gene expression analysis with limited amounts of RNA samples.
Asunto(s)
ADN Complementario/genética , Amplificación de Genes , Biblioteca de Genes , Hepatocitos/metabolismo , ARN Complementario/biosíntesis , ARN Mensajero/genética , Animales , Secuencia de Bases , Células Cultivadas , Clonación Molecular , ADN Complementario/metabolismo , Expresión Génica , Glucagón/farmacología , Glucocorticoides/farmacología , Hepatocitos/efectos de los fármacos , Metalotioneína/genética , Ratones , Datos de Secuencia Molecular , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa , ARN sin Sentido/genética , ARN Complementario/genética , ARN Mensajero/metabolismo , Ratas , Transcripción Genética/genéticaRESUMEN
Genes expressed with day/night rhythms in the mouse liver were searched for by microarray analysis using an in-house array harboring mouse liver cDNAs. The rhythmic expression with a single peak and trough level was confirmed by RNA blot analysis for 3beta-Hsd and Gabarapl1 genes exhibiting a peak in the light phase and Spot14, Hspa8, Hspa5, and Hsp84-1 genes showing a peak in the dark phase. On the other hand, mRNA levels for all of the three fibrinogen subunits, Aalpha, Bbeta and gamma, exhibited two peaks each in the light and dark phases in a synchronized manner. This two-peaked rhythmic pattern of fibrinogen genes as well as the single peak-trough pattern of other genes was diminished or almost completely lost in the liver of Clock mutant mice, suggesting that the two-peaked expression is also under the control of oscillation-generating genes. In constant darkness, the first peak of the expression rhythm of fibrinogen genes was almost intact, but the second peak disappeared. Therefore, although the first peak in the subjective day is a component of the innate circadian rhythm, the second peak seems to require light stimuli. Fasting in constant darkness caused shifts of time phases of the circadian rhythms. Protein levels of the fibrinogen subunits in whole blood also exhibited circadian rhythms. In the mouse and human loci of the fibrinogen gene cluster, a number of sequence elements resembling circadian transcription factor-binding sites were found. The fibrinogen gene locus provides a unique system for the study of two-peaked day/night rhythms of gene expression in a synchronized form.
Asunto(s)
Ritmo Circadiano/fisiología , Fibrinógeno/genética , Hígado/fisiología , Animales , Mapeo Cromosómico , Cromosomas de los Mamíferos , Chaperón BiP del Retículo Endoplásmico , Regulación de la Expresión Génica/fisiología , Masculino , Ratones , Familia de Multigenes/fisiología , Análisis de Secuencia por Matrices de OligonucleótidosRESUMEN
Carnitine palmitoyltransferase I (CPT I) is one of the carnitine cycle enzymes that plays a role in the transportation of long-fatty acids into the mitochondria for beta-oxidation. Hepatic carnitine palmitoyltransferase I (CPT IA) is one of the isozymes of CPT I, and its deficiency results in an autosomal recessive mitochondrial fatty acid oxidation disorder. To date, 19 patients with CPT IA deficiency and 9 CPT IA mutations have been reported. Recently, six novel mutations in the CPT IA gene were reported in Japanese patients with CPT I deficiencies who were clinically diagnosed as having a Reye-like syndrome. One of these mutations was a missense mutation, 1079A>G (E360G). The other was a splicing mutation, 2027-2028+2delAAGT, which caused aberrant splicing transcripts, whereas 1876-2028del, 2027-2028insGTCTCTTCC ACTTCTTCC, and 2026-2028del were three aberrant transcripts that kept reading in-frame. In this report, an expression assay using SV40 transformed fibroblasts was performed to investigate the consequences of these two mutations on enzyme activity and protein levels. Molecular analysis in this study revealed that the two mutations 1079A>G and 2028+2delAAGT were the disease-causing mutations.
Asunto(s)
Carnitina O-Palmitoiltransferasa/deficiencia , Mutación , Empalme Alternativo , Northern Blotting , Carnitina O-Palmitoiltransferasa/genética , Femenino , Humanos , Immunoblotting , Lactante , Masculino , Mutación MissenseRESUMEN
The visual system scales motion parallax signals with information about absolute distance (M. E. Ono, Rivest, & H. Ono, 1986). The present study was designed to determine whether relative distance cues, which intrinsically provide information about relative distance, contribute to this scaling. In two experiments, two test stimuli, containing an equal extent of motion parallax, were presented simultaneously at a fixed viewing distance. The relative distance cues of dynamic occlusion and motion parallax in the areas surrounding the test stimuli (background motion parallax) and/or relative size were manipulated. The observers reported which of the two parallactic test stimuli appeared to have greater depth, and which appeared to be more distant. The results showed that the test stimulus specified, by the relative distance cues, as being more distant was perceived as having more depth and as being more distant. This indicates that relative distance cues contribute to scaling depth from motion parallax by modifying the information about the absolute distance of objects.